First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome

Human Molecular Genetics

Volumn 17, Issue 19, 2008, Pages 2967-2977

  Kapeller, Johannes ^a   Houghton, Lesley A ^b   Mönnikes, Hubert ^c   Walstab, Jutta ^d   Möller, Dorothee ^a   Bönisch, Heinz ^d   Burwinkel, Barbara ^e   Autschbach, Frank ^a   Funke, Benjamin ^a   Lasitschka, Felix ^a   Gassler, Nikolaus ^f   Fischer, Christine ^a   Whorwell, Peter J ^b   Atkinson, Wendy ^b   Fell, Catherine ^b   Büchner, Karl J ^g   Schmidtmann, Marco ^c   Van der voort, Ivo ^g   Wisser, Anna Sophia ^c   Berg, Thomas ^g   Rappold, Gudrun ^a   Niesler, Beate ^a   more..

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c Martin Luther Hospital   (Germany)

^d UNIVERSITY OF BONN   (Germany)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CIS ACTING ELEMENT; CYTOSINE; GUANINE; LUCIFERASE; MICRORNA; MICRORNA 510; RECEPTOR SUBTYPE; SEROTONIN 3 RECEPTOR; SEROTONIN 3A RECEPTOR; SEROTONIN 3E RECEPTOR; THYMINE; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; BINDING SITE; COLON MUCOSA; CONTROLLED STUDY; DIARRHEA; FEMALE; GENDER BIAS; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC VARIABILITY; GERMANY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; INTESTINE CELL; INTESTINE EPITHELIUM; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; MYENTERIC PLEXUS; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PILOT STUDY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN RNA BINDING; RECEPTOR DENSITY; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROTONINERGIC SYSTEM; UNITED KINGDOM;

3' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CELL LINE; COHORT STUDIES; DIARRHEA; FEMALE; GENE EXPRESSION; GERMANY; GREAT BRITAIN; HUMANS; INTESTINAL MUCOSA; IRRITABLE BOWEL SYNDROME; MALE; MICRORNAS; MIDDLE AGED; MUTATION; RECEPTORS, SEROTONIN; SPECIES SPECIFICITY;

EID: 52949108889     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddn195     Document Type: Article

References (45)

1. Drossman, D.A., Camilleri, M., Mayer, E.A. and Whitehead, W.E. (2002) AGA technical review on irritable bowel syndrome. Gastroenterology 123, 2108-2131.
2. Longstreth, G.F., Thompson, W.G., Chey, W.D., Houghton, L.A., Mearin, F. and Spiller, R.C. (2006) Functional bowel disorders. Gastroenterology 130, 1480-1491.
3. Cole, J.A., Rothman, K.J., Cabral, H.J., Zhang, Y. and Farraye, F.A. (2006) Migraine, fibromyalgia, and depression among people with IBS: A prevalence study. BMC Gastroenterol., 6, 26.
4. Kovacs, Z. and Kovacs, F. (2007) Depressive and anxiety symptoms, dysfunctional attitudes and social aspects in irritable bowel syndrome and inflammatory bowel disease. Int. J. Psychiatry Med., 37, 245-255.
5. Bassotti, G., Chistolini, F., Marinozzi, G. and Morelli, A. (2003) Abnormal colonic propagated activity in patients with slow transit constipation and constipation-predominant irritable bowel syndrome. Digestion, 68, 178-183.
6. Chey, W.Y., Jin, H.O., Lee, M.H., Sun, S.W. and Lee, K.Y. (2001) Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea. Am. J. Gastroenterol., 96, 1499-1506.
7. Houghton, L.A. (2002) Evidence of abnormal rectal sensitivity in IBS. Camilleri, M. and Spiller, R. (eds), Irritable Bowel Syndrome: Diagnosis and Treatment., WB Saunders, London, UK, pp. 69-76.
8. Kalantar, J.S., Locke, G.R., 3rd, Zinsmeister, A.R., Beighley, C.M. and Talley, N.J. (2003) Familial aggregation of irritable bowel syndrome: A prospective study. Gut, 52, 1703-1707.
9. Lembo, A., Zaman, M., Jones, M. and Talley, N.J. (2007) Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: A twin study. Aliment. Pharmacol. Ther., 25, 1343-1350.
10. Levy, R.L., Jones, K.R., Whitehead, W.E., Feld, S.I., Talley, N.J. and Corey, L.A. (2001) Irritable bowel syndrome in twins: Heredity and social learning both contribute to etiology. Gastroenterology, 121, 799-804.
11. Bengtson, M.B., Ronning, T., Vatn, M.H. and Harris, J.R. (2006) Irritable bowel syndrome in twins: Genes and environment. Gut, 55, 1754-1759.
12. Niesler, B., Kapeller, J., Hammer, C. and Rappold, G. (2008) Serotonin type 3 Receptor genes: HTR3A, B, C, D, E. Pharmacogenomics, 9 501-504.
13. Gershon, M.D. (2005) Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome. J. Clin. Gastroenterol. 39, S184-S193.
14. Miyake, A., Mochizuki, S., Takemoto, Y. and Akuzawa, S. (1995) Molecular cloning of human 5-hydroxytryptamine3 receptor: Heterogeneity in distribution and function among species. Mol. Pharmacol., 48 407-416.
15. Davies, P.A., Pistis, M., Hanna, M.C., Peters, J.A., Lambert, J.J., Hales, T.G. and Kirkness, E.F. (1999) The 5-HT3B subunit is a major determinant of serotonin-receptor function. Nature, 397, 359-363.
16. Niesler, B., Frank, B., Kapeller, J. and Rappold, G.A. (2003) Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E. Gene, 310, 101-111.
17. Niesler, B., Walstab, J., Combrink, S., Moller, D., Kapeller, J., Rietdorf, J., Bonisch, H., Gothert, M., Rappold, G. and Bruss, M. (2007) Characterization of the novel human serotonin receptor subunits 5-HT3C, 5-HT3D, and 5-HT3E. Mol. Pharmacol., 72, 8-17.
18. Karnovsky, A.M., Gotow, L.F., McKinley, D.D., Piechan, J.L., Ruble, C.L., Mills, C.J., Schellin, K.A., Slightom, J.L., Fitzgerald, L.R., Benjamin, CW. et al. (2003) A cluster of novel serotonin receptor 3-like genes on human chromosome 3. Gene, 319, 137-148.
19. Pastinen, T., Ge, B. and Hudson, T.J. (2006) Influence of human genome polymorphism on gene expression. Hum. Mol. Genet., 15(Spec No. 1), R9-R16.
20. Knight, J.C. (2005) Regulatory polymorphisms underlying complex disease traits. J. Mol. Med., 83, 97-109.
21. Wray, G.A. (2007) The evolutionary significance of cis-regulatory mutations. Nat. Rev. Genet., 8, 206-216.
22. Griffiths-Jones, S., Grocock, R.J., van Dongen, S., Bateman, A. and Enright, A.J. (2006) miRBase: MicroRNA sequences, targets and gene nomenclature. Nucleic Acids Res., 34, D140-D144.
23. Niesler, B., Flohr, T., Nöthen, M.M., Fischer, C., Rietschel, M., Franzek, E., Albus, M., Propping, P. and Rappold, G.A. (2001) Association between the 5′-UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder. Pharmacogenetics, 11 471-475.
24. Bartel, D.P. (2004) MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell, 116, 281-297.
25. He, L. and Hannon, G.J. (2004) MicroRNAs: Small RNAs with a big role in gene regulation. Nat. Rev. Genet., 5, 522-531.
26. Martin, M.M., Buckenberger, J.A., Jiang, J., Malana, G.E., Nuovo, G.J., Chotani, M., Feldman, D.S., Schmittgen, T.D. and Elton, T.S. (2007) The human angiotensin II type 1 receptor + 1166 A/C polymorphism attenuates microma-155 binding. J. Biol. Chem., 282, 24262-24269.
27. Saunders, M.A,, Liang, H. and Li, W.H. (2007) Human polymorphism at microRNAs and microRNA target sites. Proc. Natl Acad. Sci. USA, 104, 3300-3305.
28. Yu, Z., Li, Z., Jolicoeur, N., Zhang, L., Fortin, Y., Wang, E., Wu, M. and Shen, S.H. (2007) Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic Acids Res., 35, 4535-4541.
29. Abelson, J.F., Kwan, K.Y., O'Roak, B.J., Baek, D.Y., Stillman, A.A., Morgan, T.M., Mathews, C.A., Pauls, D.L., Rasin, M.R., Gunel, M. et al. (2005) Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science, 310, 317-320.
30. Tan, Z., Randall, G., Fan, J., Camoretti-Mercado, B., Brockman-Schneider, R., Pan, L., Solway, J., Gern, J.E., Lemanske, R.F., Nicolae, D. et al. (2007) Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am. J. Hum. Genet., 81, 829-834.
31. Ouyang, A. and Wrzos, H.F. (2006) Contribution of gender to pathophysiology and clinical presentation of IBS: Should management be different in women? Am. J. Gastroenterol., 101, S602-S609.
32. Engelmann, B.E., Bindslev, N., Poulsen, S.S., Larsen, R. and Hansen, M.B. (2006) Functional characterization of serotonin receptor subtypes in human duodenal secretion. Basic Clin. Pharmacol. Toxicol., 98, 142-149.
33. Morris, D.R. and Geballe, A.P. (2000) Upstream open reading frames as regulators of mRNA translation. Mol. Cell. Biol., 20, 8635-8642.
34. Iidaka, T., Ozaki, N., Matsumoto, A., Nogawa, J., Kinoshita, Y., Suzuki, T., Iwata, N., Yamamoto, Y., Okada, T. and Sadato, N. (2005) A variant C178T in the regulatory region of the serotonin receptor gene HTR3A modulates neural activation in the human amygdala. J. Neurosci., 25, 6460-6466.
35. Melke, J., Westberg, L., Nilsson, S., Landen, M., Soderstrom, H., Baghaei, F., Rosmond, R., Holm, G., Bjorntorp, P., Nilsson, L.G. et al. (2003) A polymorphism in the serotonin receptor 3A (HTR3A) gene and its association with harm avoidance in women. Arch. Gen. Psychiatry, 60, 1017-1023.
36. Michel, K., Zeller, F., Langer, R., Nekarda, H., Kruger, D., Dover, T.J., Brady, C.A., Barnes, N.M. and Schemann, M. (2005) Serotonin excites neurons in the human submucous plexus via 5-HT3 receptors. Gastroenterology, 128, 1317-1326.
37. Gershon, M.D. and Tack, J. (2007) The serotonin signaling system: From basic understanding to drug development for functional GI disorders. Gastroenterology, 132, 397-414.
38. Simren, M., Simms, L., D'Souza, D., Abrahamsson, H. and Bjornsson, E.S. (2003) Lipid-induced colonic hypersensitivity in irritable bowel syndrome: The role of 5-HT3 receptors. Aliment. Pharmacol. Ther., 17, 279-287.
39. Berman, S.M., Chang, L., Suyenobu, B., Derbyshire, S.W., Stains, J., Fitzgerald, L., Mandelkern, M., Hamm, L., Vogt, B., Naliboff, B.D. et al. (2002) Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron. Gastroenterology, 123, 969-977.
40. Mayer, E.A., Berman, S., Derbyshire, S.W., Suyenobu, B., Chang, L., Fitzgerald, L., Mandelkern, M., Hamm, L., Vogt, B. and Naliboff, B.D. (2002) The effect of the 5-HT3 receptor antagonist, alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients. Aliment. Pharmacol. Ther., 16, 1357-1366.
41. Spiller, R., Aziz, Q., Creed, F., Emmanuel, A., Houghton, L., Hungin, P., Jones, R., Kumar, D., Rubin, G., Trudgill, N. et al. (2007) Guidelines for the management of Irritable Bowel Syndrome. Gut, 56, 1770-1798.
42. Thompson, W.G., Longstreth, G.F., Drossman, D.A., Heaton, K.W., Irvine, E.J. and Muller-Lissner, S.A. (1999) Functional bowel disorders and functional abdominal pain. Gut, 45 (Suppl. 2), II43-II47.
43. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual., 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, USA.
44. Ernsberger, U., Patzke, H. and Rohrer, H. (1997) The developmental expression of choline acetyltransferase (ChAT) and the neuropeptide VIP in chick sympathetic neurons: Evidence for different regulatory events in cholinergic differentiation. Mech. Dev., 68, 115-126.
45. Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.